Toxic hepatitis occurs when liver develops inflammation because of exposure to a toxic substance. Toxic hepatitis may also develop when you take too much of a prescription or over-the-counter medication. Mild forms of toxic hepatitis may not cause any symptoms and may be detected only by blood tests. Symptoms of toxic hepatitis include nausea and vomiting, rash, weight loss, dark or tea-colored urine. New estimates based on preliminary data show that hepatitis prevalence in France is 0.86%. There are no proper studies to report the incidence of toxic hepatitis. Every drug manufactured causes some form of liver damage or the other.
There is no treatment for most types of toxic hepatitis. If a person is diagnosed with this condition, the toxin should be discontinued immediately and avoided in the future. IV fluid is recommended for people who experience extreme nausea and vomiting. Symptoms usually go away within a few days or weeks. However, in severe cases, or if the condition was left untreated, toxic hepatitis can lead to irreversible liver failure and requires a liver transplant. Since the early 1990s, prevention and control of hepatitis was already considered a public health priority in France. France’s national hepatitis programs have resulted in more effective screening campaigns, enhanced hepatitis surveillance systems, and excellent hepatitis research programs that are funded by a wide range of sources, some of which include the ANRS / ANRH, the European Commission, and external grants and scholarships.